nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxyphencyclimine—Biperiden—ABCB1—adrenal gland cancer	0.31	1	CrCbGaD
Oxyphencyclimine—CHRM1—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.0294	0.0425	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCRs, Other—GNRHR—adrenal gland cancer	0.029	0.042	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCRs, Other—GNRHR—adrenal gland cancer	0.0287	0.0416	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0196	0.0284	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0195	0.0283	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0193	0.028	CbGpPWpGaD
Oxyphencyclimine—CHRM1—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0163	0.0237	CbGpPWpGaD
Oxyphencyclimine—CHRM3—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0163	0.0236	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0146	0.0212	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0146	0.0211	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Regulation of insulin secretion—PRKACA—adrenal gland cancer	0.0127	0.0184	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0108	0.0157	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0108	0.0156	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0107	0.0155	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Regulation of insulin secretion—GNAS—adrenal gland cancer	0.0103	0.0149	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Integration of energy metabolism—PRKACA—adrenal gland cancer	0.00998	0.0145	CbGpPWpGaD
Oxyphencyclimine—CHRM1—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00979	0.0142	CbGpPWpGaD
Oxyphencyclimine—CHRM3—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00976	0.0141	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00875	0.0127	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00873	0.0126	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00824	0.0119	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00821	0.0119	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00813	0.0118	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Integration of energy metabolism—GNAS—adrenal gland cancer	0.00809	0.0117	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00751	0.0109	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00748	0.0108	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00741	0.0107	CbGpPWpGaD
Oxyphencyclimine—CHRM2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00714	0.0103	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00671	0.00972	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00648	0.00939	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00646	0.00936	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0064	0.00927	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00637	0.00922	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00635	0.00919	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00629	0.0091	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00609	0.00881	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00607	0.00878	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00601	0.0087	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00578	0.00837	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00576	0.00834	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0057	0.00826	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00494	0.00715	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00492	0.00713	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00487	0.00706	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00466	0.00674	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00464	0.00672	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.0046	0.00666	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.0044	0.00637	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR ligand binding—TSHR—adrenal gland cancer	0.00439	0.00635	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00434	0.00629	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00423	0.00612	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00421	0.0061	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00417	0.00604	CbGpPWpGaD
Oxyphencyclimine—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00417	0.00604	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00405	0.00586	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00403	0.00584	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00399	0.00578	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—SDHB—adrenal gland cancer	0.00326	0.00471	CbGpPWpGaD
Oxyphencyclimine—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00281	0.00407	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00279	0.00404	CbGpPWpGaD
Oxyphencyclimine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00278	0.00403	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00278	0.00403	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00275	0.00399	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00256	0.00371	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00255	0.00369	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00253	0.00367	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00253	0.00366	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00252	0.00366	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.0025	0.00362	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.0025	0.00362	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—GNRHR—adrenal gland cancer	0.00249	0.00361	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00249	0.0036	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00248	0.00359	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00247	0.00357	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00245	0.00355	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00232	0.00336	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00232	0.00336	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00231	0.00335	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00231	0.00334	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00229	0.00332	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00229	0.00331	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00226	0.00328	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00226	0.00327	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00226	0.00327	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—TSHR—adrenal gland cancer	0.00225	0.00326	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00223	0.00323	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.00223	0.00323	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00218	0.00316	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00218	0.00315	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00216	0.00312	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—RRM1—adrenal gland cancer	0.0021	0.00304	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—SDHD—adrenal gland cancer	0.0021	0.00304	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00173	0.0025	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.00172	0.0025	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00172	0.00249	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR ligand binding—POMC—adrenal gland cancer	0.00172	0.00249	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.0017	0.00246	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00162	0.00235	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00162	0.00234	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.0016	0.00232	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—MED12—adrenal gland cancer	0.00156	0.00227	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Circadian rythm related genes—TP53—adrenal gland cancer	0.00153	0.00222	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00151	0.00219	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00151	0.00218	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—GNRH1—adrenal gland cancer	0.0015	0.00217	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00149	0.00216	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—GNRH1—adrenal gland cancer	0.00149	0.00216	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00148	0.00214	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00145	0.00209	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00144	0.00209	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00143	0.00207	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00137	0.00199	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—CDC42—adrenal gland cancer	0.00137	0.00198	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00137	0.00198	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—SPRY2—adrenal gland cancer	0.00136	0.00198	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.00136	0.00196	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.00135	0.00196	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	0.00133	0.00193	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—TSHR—adrenal gland cancer	0.00133	0.00193	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.00132	0.00191	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00131	0.0019	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—GNAS—adrenal gland cancer	0.00131	0.0019	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.0013	0.00188	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	0.00125	0.00182	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—MEN1—adrenal gland cancer	0.00125	0.00181	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.00124	0.00179	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PRKACA—adrenal gland cancer	0.00114	0.00165	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000974	0.00141	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000971	0.00141	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000961	0.00139	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000957	0.00139	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000954	0.00138	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000945	0.00137	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—GNAS—adrenal gland cancer	0.000925	0.00134	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—ABCB1—adrenal gland cancer	0.000907	0.00131	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	0.000884	0.00128	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	0.000881	0.00128	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000873	0.00126	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.000812	0.00118	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	0.000809	0.00117	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000801	0.00116	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.000783	0.00113	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	0.00078	0.00113	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.000776	0.00112	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	0.000773	0.00112	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000772	0.00112	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.000766	0.00111	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000757	0.0011	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000754	0.00109	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000747	0.00108	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	0.000651	0.000943	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	0.000649	0.00094	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.000643	0.000931	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—POMC—adrenal gland cancer	0.000623	0.000902	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	0.000567	0.000821	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	0.000565	0.000818	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000559	0.00081	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	0.000522	0.000756	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	0.000521	0.000754	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	0.000516	0.000747	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.000516	0.000747	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	0.000514	0.000745	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000509	0.000737	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	0.0005	0.000724	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000498	0.000722	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PTGS2—adrenal gland cancer	0.000497	0.000719	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000494	0.000715	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000373	0.00054	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000372	0.000538	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000368	0.000533	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	0.000295	0.000428	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	0.000294	0.000426	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	0.000292	0.000422	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	0.000248	0.000359	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	0.000247	0.000358	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	0.000245	0.000355	CbGpPWpGaD
